CoChat

Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice

Open access
Blüher, Susann, Ziotopoulou, Mary, Bullen, John W., Moschos, Stergios J., Ungsunan, Linda, Kokkotou, Efi, Maratos-Flier, Eleftheria, Mantzoros, Christos S. · 2004 · Diabetes
Cited by 89

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

To elucidate mechanisms of melanocortin action, we investigated the effects of a melanocortin receptor agonist (melanotetan II [MTII]) in lean C57BL/6J and obese (DIO, ob/ob, UCP1-DTA) mice. MTII administration (100 μg q.i.d. i.p.) for 24 h results in similar weight loss but a more pronounced decrease of food intake in DIO mice. After 4 and 8 days of MTII treatment, however, the reduction in both food intake and body weight is more pronounced in DIO mice than in lean mice. MTII administration for 24 h prevents food deprivation-induced alterations in hypothalamic neuropeptide Y (NPY) and liver adiponectin receptor 1 and adiponectin receptor 2 mRNA expression, but does not alter hypothalamic mRNA expression of melanocortin 4 receptor or adiponectin serum and mRNA expression levels. NPY and agouti gene-related protein (AgRP) mRNA expression after 8 days of MTII is increased to levels comparable to pair-fed mice. In summary, 1) MTII is an effective treatment for obesity and related metabolic defects in leptin-resistant (DIO, UCP1-DTA) and leptin-sensitive (ob/ob) mouse models of obesity; 2) the effects of MTII on food intake and body weight are more pronounced in DIO mice than in lean mice; 3) the tachyphylactic effect after prolonged MTII administration appears to be, at least in part, caused by a compensatory upregulation of NPY and AgRP mRNA levels, whereas decreasing leptin levels may play a very minor role in mediating tachyphylaxis; and 4) alterations in adiponectin receptor mRNA expression after fasting or MTII treatment may contribute to altered insulin sensitivity and needs to be studied further.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.53.1.82

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 29

  1. Yaswen L, Diehl N, Brennan MB, Hochgeschwender U: Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Nat Med 5: 1066–1070,1999 · DOI · Paper page
  2. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, Yu H, Rosenblum CI, Vongs A, Feng Y, Cao L, Metzger JM, Strack AM, Camacho RE, Mellin TN, Nunes CN, Min W, Fisher J, Gopal-Truter S, MacIntyre DE, Chen HY, Van der Ploeg LH: Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat Genet 26: 97–102,2000 · DOI · Paper page
  3. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165–168,1997 · DOI · Paper page
  4. Marsh DJ, Hollopeter G, Huszar D, Laufer R, Yagaloff KA, Fisher SL, Bum P, Palmiter RD: Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat Genet 21: 119–122,1999 · DOI · Paper page
  5. Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G, Steiner RA: Differential role of melanocortins in mediating leptin’s central effects on feeding and reproduction. Am J Physiol Regul Integr Comp Physiol 278: R50–R59,2000 · DOI · Paper page
  6. Koegler FH, Grove KL, Schiffmacher A, Smith MS, Cameron JL: Central melanocortin receptors mediate changes in food intake in the rhesus macaque. Endocrinology 142: 2586–2592,2001 · doi:10.1210/endo.142.6.8198 · Paper page
  7. Murphy B, Nunes CN, Ronan JJ, Hanaway M, Fairhurst AM, Mellin TN: Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J Appl Physiol 89: 273–282,2000 · DOI · Paper page
  8. Forbes S, Bui S, Robinson BR, Hochgeschwender U, Brennan MB: Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway. Proc Natl Acad Sci U S A 98: 4233–4237,2001 · DOI · Paper page
  9. Satoh N, Ogawa Y, Katsuura G, Numuta Y, Masuzaki H, Yoshimasa Y, Nakao K: Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249: 107–110,1998 · DOI · Paper page
  10. Kask A, Schioth HB, Harro J, Wikberg JE, Rago L: Longitudinal administration of MC4 receptor antagonist HS014 causes hyperphagia and obesity in rats. Neuroreport 10: 707–711,1999 · DOI
  11. Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS: Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51: 1337–1345,2002 · DOI · Paper page
  12. Mantzoros CS, Qu D, Frederich RC, Susulic VS, Lowell BB, Maratos-Flier E, Flier JS: Activation of β(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice. Diabetes 45: 909–914,1996 · DOI · Paper page
  13. Ziotopoulou M, Mantzoros CS, Hileman SM, Flier JS: Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 279: E838–E845,2000 · DOI · Paper page
  14. Ziotopoulou M, Erani DM, Hileman SM, Bjorbaek C, Mantzoros CS: Unlike leptin, ciliary neurotrophic factor does not reverse the starvation induced changes of serum corticosterone and hypothalamic neuropeptide levels but induces expression of hypothalamic inhibitors of leptin signaling. Diabetes 49: 1890–1896,2000 · DOI
  15. Shinyama H, Masuzaki H, Fang H, Flier JS: Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology 144: 1301–1314,2003 · DOI · Paper page
  16. Jonsson L, Skarphedinsson JO, Skuladottir GV, Atlason PT, Eiriksdottir LF, Schiöth HB: Melanocortin receptor agonist transiently increases oxygen consumption in rats. Neuroreport 12: 3703–3708,2001 · DOI
  17. Hamann A, Flier JS, Lowell BB: Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137: 21–29,1996 · doi:10.1210/endo.137.1.8536614 · Paper page
  18. Mantzoros CS, Frederich RC, Qu D, Lowell BB, Maratos-Flier E, Flier JS: Severe leptin resistance in brown fat-deficient uncoupling protein promoter-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptideY and circulating corticosterone concentrations. Diabetes 47: 230–238,1998 · DOI · Paper page
  19. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425–432,1994 · DOI · Paper page
  20. Hwa JJ, Ghibaudi L, Gao J, Parker EM: Central melanocortin system modulated energy intake and expenditure of obese and lean Zucker rats. Am J Physiol Regul Integr Comp Physiol 281: R444–R451,2001 · DOI · Paper page
  21. Cettour-Rose P, Rohner-Jeanrenaud F: The leptin-like effects of 3-d peripheral administration of a melanocortin agonist are more marked in genetically obese Zucker (fa/fa) than in lean rats. Endocrinology 143: 2277–2283,2002 · doi:10.1210/endo.143.6.8871 · Paper page
  22. Hansen MJ, Ball MJ, Morris MJ: Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat. Brain Res 892: 130–137,2001 · DOI
  23. McMinn JE, Wilkinson CW, Havel PJ, Woods SC, Schwartz MW: Effect of intracerebroventricular alpha-MHS on food intake, adiposity, c-FOS induction, and neuropeptide expression. Am J Physiol Regul Integr Comp Physiol 27: R695–R703,2000 · DOI · Paper page
  24. Jonsson L, Skarphedinsson JO, Skuladottir GV, Watanobe H, Schioth HB: Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J Endocrinol 173: 517–523,2002 · DOI · Paper page
  25. Garcia de Yebenes E, Li S, Fournier A, St-Pierre S, Pelletier G: Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus. Brain Res 674: 112–116,1995 · DOI
  26. Ishihara A, Tanaka T, Kanatani A, Fukami T, Ihara M, Fukuroda T: A potent neuropeptide Y antagonist, 1229U91, suppressed spontaneous food intake in Zucker fatty rats. Am J Physiol 274: R1500–R1504,1998 · DOI
  27. Marsh DJ, Miura GI, Yagaloff KA, Schwartz MW, Barsh GS, Palmiter RD: Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues. Brain Res 848: 66–77,1999 · DOI
  28. Kim MS, Rossi M, Abusnana S, Sunter D, Morgan DG, Small CJ, Edwards CM, Heath MM, Stanley SA, Seal LJ, Bhatti JR, Smith DM, Ghatei MA, Bloom SR: Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes 49: 177–182,2000 · DOI · Paper page
  29. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R: Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 10: 1095–1103,2002 · DOI · Paper page

Cited by

See all 89

Metadata

Authors
Blüher, S., Ziotopoulou, M., Bullen, J. W., Moschos, S. J., Ungsunan, L., Kokkotou, E., Maratos-Flier, E., & Mantzoros, C. S.
Venue
Diabetes
Published
2004-01-01
Volume
53
Issue
1
Pages
82-90
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2122686314
Cited by
89
References
9
FWCI
4.23
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice. https://app.cochat.ai/papers/10.2337/diabetes.53.1.82
The paper
Blüher, S., Ziotopoulou, M., Bullen, J. W., Moschos, S. J., Ungsunan, L., Kokkotou, E., Maratos-Flier, E., & Mantzoros, C. S. (2004). Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice. Diabetes. https://doi.org/10.2337/diabetes.53.1.82

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.